Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Webcast of February 4, 2009 Vaccine Safety Working Group Meeting
The of the National Vaccine Advisory Committee, NVAC) has sought broad public input into the scientific research agenda that is being developed by the Centers for Disease Control and Prevention's (CDC) Immunization Safety Office (ISO).
At its , the NVAC Vaccine Safety Working Group discussed outcomes and issues highlighted in three public engagement sessions held earlier in Birmingham, Alabama; Ashland, Oregon; and Indianapolis, Indiana. A summary of the written comments sent to HHS on the CDC ISO research agenda was also discussed.
- View the archived Webcast - 270 minutes.
[RealPlayer is required to view the Webcast.]
|
|
Bernard Richard, Indianapolis, IN Overview: Why did you attend a community meeting about vaccine saftey? Duration: 2:12 minutes |
 |
Tracy Cron, Birmingham, AL - 1:47 minutes |
 |
Toni DiLeo, Ashland, OR - 2:23 minutes |
 |
Bernard Richard, Indianapolis, IN - 2:12 minutes |
 |
Andy Pavia, MD, Chair, NVAC Vaccine Safety Working Group - 1:24 minutes |